Skip to main content
low healthVERIFIED📡 SPREADING

Infosan opens EUR 3 million myopia center in Bucharest

Verified: 3 outlets have reported this story since Nov 17, 3 of them from Romania.

📍 Bucharest, RO·🕐 1h ago·3 outlets

Pediatric ophthalmology hospital Infosan, founded by Dr. Călin Ciubotaru and Dr. Andreea Ciubotaru, has opened a Myopia Center, an investment of approximately EUR 3 million financed entirely from the company's own funds. The center, located in Bucharest’s Iancului area, is dedicated to the assessment, diagnosis, monitoring and management of myopia in both children and adults. With a total area of approximately 1,500 sqm, it spreads on four levels, with 18 specialized consultation rooms, dedicated areas for diagnostic investigations and treatment, and optical services. Continue reading on…

How sure are we

✓ Verified · 3 outlets

Two or more outlets reported this story and its reliability score reached 65%, so WorldPulse marks it verified. That means more than one outlet says so, not that it is proven true.

How we count · Check a link someone shared

Who reported it

The story so far · 3 reports · ✓ Verified Nov 17, 7:08 PM UTC

3 outlets from Romania, where the story is: Business Review, Romania Insider, ZF English · how we count

  1. Nov 17, 3:40 PM UTCFirst report
    Infosan opens a myopia center following a EUR 3 million investmentbusiness-review.eu ↗
  2. Nov 17, 7:08 PM UTC+3 h
    Infosan Opens Myopia Center In Bucharest In Wake Of EUR3M Investmentzfenglish.com ↗
  3. Verified: a second independent outlet reported itNov 17, 7:08 PM UTC · +3 h
  4. Nov 18, 12:50 PM UTC+21 h· you’re reading this
    Infosan opens EUR 3 million myopia center in Bucharestromania-insider.com ↗
Location
Verification Log1
cross checkconfirmed90%

[Claude] Both other reports cover the same Infosan myopia center opening in Bucharest with the roughly EUR 3 million self-funded investment, with no conflicting facts.

1h ago
Powered by WorldPulse Verification Engine
Discussion (0)

Sign in to join the discussion

No discussion yet — be the first to add context.

Reliability
92%

Very high · How we score this

Risk Score
low risk